Clinical Trial Detail

NCT ID NCT02576665
Title A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects With Solid Tumors (Toca6)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tocagen Inc.
Indications

lung non-small cell carcinoma

renal cell carcinoma

pancreatic cancer

Advanced Solid Tumor

breast cancer

colorectal cancer

melanoma

Therapies

Toca 511 + Toca FC

Age Groups: adult senior

No variant requirements are available.